236 related articles for article (PubMed ID: 12456809)
1. Partial rescue of the Hyp phenotype by osteoblast-targeted PHEX (phosphate-regulating gene with homologies to endopeptidases on the X chromosome) expression.
Bai X; Miao D; Panda D; Grady S; McKee MD; Goltzman D; Karaplis AC
Mol Endocrinol; 2002 Dec; 16(12):2913-25. PubMed ID: 12456809
[TBL] [Abstract][Full Text] [Related]
2. A novel Phex mutation in a new mouse model of hypophosphatemic rickets.
Owen C; Chen F; Flenniken AM; Osborne LR; Ichikawa S; Adamson SL; Rossant J; Aubin JE
J Cell Biochem; 2012 Jul; 113(7):2432-41. PubMed ID: 22573557
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Phex in osteoblasts fails to rescue the Hyp mouse phenotype.
Liu S; Guo R; Tu Q; Quarles LD
J Biol Chem; 2002 Feb; 277(5):3686-97. PubMed ID: 11713245
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of human PHEX under the human beta-actin promoter does not fully rescue the Hyp mouse phenotype.
Erben RG; Mayer D; Weber K; Jonsson K; Jüppner H; Lanske B
J Bone Miner Res; 2005 Jul; 20(7):1149-60. PubMed ID: 15940367
[TBL] [Abstract][Full Text] [Related]
5. Osteomalacia in hyp mice is associated with abnormal phex expression and with altered bone matrix protein expression and deposition.
Miao D; Bai X; Panda D; McKee M; Karaplis A; Goltzman D
Endocrinology; 2001 Feb; 142(2):926-39. PubMed ID: 11159866
[TBL] [Abstract][Full Text] [Related]
6. Coordinated maturational regulation of PHEX and renal phosphate transport inhibitory activity: evidence for the pathophysiological role of PHEX in X-linked hypophosphatemia.
Nesbitt T; Fujiwara I; Thomas R; Xiao ZS; Quarles LD; Drezner MK
J Bone Miner Res; 1999 Dec; 14(12):2027-35. PubMed ID: 10620061
[TBL] [Abstract][Full Text] [Related]
7. Aberrant Phex function in osteoblasts and osteocytes alone underlies murine X-linked hypophosphatemia.
Yuan B; Takaiwa M; Clemens TL; Feng JQ; Kumar R; Rowe PS; Xie Y; Drezner MK
J Clin Invest; 2008 Feb; 118(2):722-34. PubMed ID: 18172553
[TBL] [Abstract][Full Text] [Related]
8. The effects of bone marrow transplantation on X-linked hypophosphatemic mice.
Miyamura T; Tanaka H; Inoue M; Ichinose Y; Seino Y
J Bone Miner Res; 2000 Aug; 15(8):1451-8. PubMed ID: 10934643
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylated acidic serine-aspartate-rich MEPE-associated motif peptide from matrix extracellular phosphoglycoprotein inhibits phosphate regulating gene with homologies to endopeptidases on the X-chromosome enzyme activity.
Liu S; Rowe PS; Vierthaler L; Zhou J; Quarles LD
J Endocrinol; 2007 Jan; 192(1):261-7. PubMed ID: 17210763
[TBL] [Abstract][Full Text] [Related]
10. Proteolytic processing of osteopontin by PHEX and accumulation of osteopontin fragments in Hyp mouse bone, the murine model of X-linked hypophosphatemia.
Barros NM; Hoac B; Neves RL; Addison WN; Assis DM; Murshed M; Carmona AK; McKee MD
J Bone Miner Res; 2013 Mar; 28(3):688-99. PubMed ID: 22991293
[TBL] [Abstract][Full Text] [Related]
11. Developmental expression and tissue distribution of Phex protein: effect of the Hyp mutation and relationship to bone markers.
Ruchon AF; Tenenhouse HS; Marcinkiewicz M; Siegfried G; Aubin JE; DesGroseillers L; Crine P; Boileau G
J Bone Miner Res; 2000 Aug; 15(8):1440-50. PubMed ID: 10934642
[TBL] [Abstract][Full Text] [Related]
12. Pathogenic role of Fgf23 in Hyp mice.
Liu S; Zhou J; Tang W; Jiang X; Rowe DW; Quarles LD
Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E38-49. PubMed ID: 16449303
[TBL] [Abstract][Full Text] [Related]
13. Increased cathepsin D release by Hyp mouse osteoblast cells.
Matsumoto N; Jo OD; Shih RN; Brochmann EJ; Murray SS; Hong V; Yanagawa J; Yanagawa N
Am J Physiol Endocrinol Metab; 2005 Jul; 289(1):E123-32. PubMed ID: 15958652
[TBL] [Abstract][Full Text] [Related]
14. Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice.
Liu S; Tang W; Zhou J; Vierthaler L; Quarles LD
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1636-44. PubMed ID: 17848631
[TBL] [Abstract][Full Text] [Related]
15. Aberrant cementum phenotype associated with the hypophosphatemic hyp mouse.
Fong H; Chu EY; Tompkins KA; Foster BL; Sitara D; Lanske B; Somerman MJ
J Periodontol; 2009 Aug; 80(8):1348-54. PubMed ID: 19656036
[TBL] [Abstract][Full Text] [Related]
16. Preproenkephalin (Penk) is expressed in differentiated osteoblasts, and its deletion in Hyp mice partially rescues their bone mineralization defect.
Seitz S; Barvencik F; Gebauer M; Albers J; Schulze J; Streichert T; Amling M; Schinke T
Calcif Tissue Int; 2010 Apr; 86(4):282-93. PubMed ID: 20204609
[TBL] [Abstract][Full Text] [Related]
17. Cartilage abnormalities are associated with abnormal Phex expression and with altered matrix protein and MMP-9 localization in Hyp mice.
Miao D; Bai X; Panda DK; Karaplis AC; Goltzman D; McKee MD
Bone; 2004 Apr; 34(4):638-47. PubMed ID: 15050894
[TBL] [Abstract][Full Text] [Related]
18. Increased Col10a1 expression is not causative for the phenotype of Phex-deficient Hyp mice.
Yorgan T; Rendenbach C; Jeschke A; Amling M; Cheah KS; Schinke T
Biochem Biophys Res Commun; 2013 Dec; 442(3-4):209-13. PubMed ID: 24269824
[TBL] [Abstract][Full Text] [Related]
19. Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP.
Martin A; David V; Laurence JS; Schwarz PM; Lafer EM; Hedge AM; Rowe PS
Endocrinology; 2008 Apr; 149(4):1757-72. PubMed ID: 18162525
[TBL] [Abstract][Full Text] [Related]
20. FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization.
Quarles LD
Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E1-9. PubMed ID: 12791601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
